Past Events

A New, Better Normal in Health Care? - National Review
The COVID-19 crisis has fast-tracked long-contemplated, patient-centric changes in medicine.
BioCentury This Week: Special Edition - Getting Real about COVID-19 Data
Amy Abernethy, FDA’s principal deputy commissioner and acting CIO, and Mark McClellan, director of the Duke-Margolis Center for Health Policy at Duke University, described in podcast interviews with BioCentury’s Washington
Health, Defense Agencies Should Cooperate to Beat COVID-19 - RealClearHealth
The U.S. has been trying to contain COVID-19 through testing and social distancing. Now it’s time to kill it.
Beyond the Magic Bullet: Medical Progress Is Often Incremental - National Review
Life won’t completely return to normal while the novel coronavirus remains a threat to health and to life.
Accelerating the collection of real-world data about COVID-19 - Biocentury
The Reagan-Udall Foundation and Friends of Cancer Research are trying to put real-world data to use against COVID-19.
Politico Prescription Pulse
Document Drawer
Real-World Evidence On COVID-19: US FDA Approaching With 'Sense Of Urgency' - Pink Sheet
"Identifying key questions and core data elements is at the heart of a new initiative launched by the Reagan-Udall Foundation and Friends of Cancer Research.
First Look at Gilead Drug Virus Response to Open Data Floodgates - Bloomberg Law
"A new initiative called the 
COVID-19 Evidence Accelerator Leverages Real-World Evidence in FDA’s Response to Global Pandemic
The Reagan-Udall Foundation for the FDA (Foundation) in collaboration with Friends of Cancer Research (Friends) today announced the COVID-19 Evidence Accelerator, an expan
One-Stop Resource Helps Patients and Healthcare Providers Link to COVID-19 Clinical Trials and Expanded Access Programs
To help patients, caregivers, physicians, and other healthcare providers find COVID-19 treatment resources as quickly and easily as possible, the Reagan-Udall Foundation for the FDA today launched the onl